 |
 | Wendell Wierenga, PhD
|
|
|
|
| Wendell Wirienga, PhD, is Executive Vice President for Research & Development at Ambit Biosciences, in San Diego. He previously served as Executive Vice President of R&D at Neurocrine Biosciences, where he managed a portfolio of six clinical programs including five INDs and two NDAs. Prior to Neurocrine Biosciences, he served as Chief Executive Officer of Syrrx, Inc. (now Takeda San Diego) and as Senior Vice President of Worldwide Pharmaceutical Sciences, Technologies and Development at Parke-Davis/Warner Lambert (now Pfizer). Prior to joining Parke-Davis, Wierenga spent 16 years at Upjohn Pharmaceuticals, where he led cancer and infectious diseases research and later drug discovery research. | |
|
